SCHEMBL18406798

SCHEMBL18406798

CNC(=O)c1ccc([N+](=O)OC)cc1CN1CCN(CC(=O)OC(C)(C)C)CC1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.34
▸ LMNA P02545 2/20 0.34
▸ MMP1 P03956 1/20 0.34
▸ MMP9 P14780 1/20 0.34
▸ MMP13 P45452 1/20 0.34
▸ ADAM17 P78536 1/20 0.34
▸ SMN1; SMN2 Q16637 2/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ MGLL Q99685 1/20 0.32
▸ KCNJ1 P48048 1/20 0.32
▸ VEGFA P15692 1/20 0.32
▸ EGLN1 Q9GZT9 1/20 0.32
▸ WNT1 P04628 1/20 0.31
▸ GSK3B P49841 1/20 0.31
▸ DYRK1A Q13627 1/20 0.31
▸ HTR4 Q13639 1/20 0.31
▸ ACKR3 P25106 1/20 0.31
▸ PDGFRB P09619 1/20 0.31
▸ FGFR1 P11362 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17155173 0.89 ALDH1A1 (0.43) ALDH1A1LMNASMN1; SMN2KDM4EHTT
SCHEMBL17153216 0.83 ACHE (0.37) ALDH1A1LMNAMMP1MMP9MMP13
SCHEMBL17152947 0.80 ALDH1A1 (0.52) ALDH1A1LMNASMN1; SMN2KDM4EHTT
SCHEMBL17152953 0.79 HTR4 (0.33) ALDH1A1LMNAMMP1MMP9MMP13
SCHEMBL17152952 0.78 ALDH1A1 (0.45) ALDH1A1LMNASMN1; SMN2KDM4EHTT
SCHEMBL18412514 0.77 L3MBTL1 (0.43) ALDH1A1LMNASMN1; SMN2KDM4EHTT
SCHEMBL17152954 0.77 ALDH1A1 (0.43) ALDH1A1LMNASMN1; SMN2KDM4EHTT
SCHEMBL17152949 0.72 CTSB (0.44) ALDH1A1LMNASMN1; SMN2KDM4EHTT
SCHEMBL9883952 0.71 ALDH1A1 (0.48) ALDH1A1LMNASMN1; SMN2KDM4EHTT
SCHEMBL17154922 0.70 ACHE (0.39) ALDH1A1SMN1; SMN2KDM4EHTTMGLL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170022201-A1 MACROCYLIC PYRIDINE DERIVATIVES JANSSEN PHARMACEUTICA NV (BE) 2017-01-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170022201-A1 MACROCYLIC PYRIDINE DERIVATIVES VPS26B, VPS4B, VPS28 ALDH1A1 4381/4885LMNA 4810/4885MMP1 4777/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback